Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Dishman Carbogen Amcis Ltd. ( (IN:DCAL) ) has provided an update.
Dishman Carbogen Amcis Ltd. has released an investor presentation in compliance with SEBI regulations, which is now available on their website. This move is part of the company’s commitment to transparency and regular communication with stakeholders, potentially impacting investor relations positively.
More about Dishman Carbogen Amcis Ltd.
Dishman Carbogen Amcis Ltd. operates in the pharmaceutical industry, focusing on providing contract research and manufacturing services. The company is known for its expertise in the development and production of active pharmaceutical ingredients (APIs) and intermediates, catering to a global market.
Average Trading Volume: 15,243
Technical Sentiment Signal: Strong Buy
Current Market Cap: 42.86B INR
Find detailed analytics on DCAL stock on TipRanks’ Stock Analysis page.